Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider
Nykode Therapeutics ASA (NYKD) · publisert 24. november 2025 kl. 16:40 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass |
|---|---|---|---|---|---|---|---|
| Michael Engsig | – | Kjøp | 46 356 | 2,16 NOK | 24. november 2025 | NO0010714785 | XOSL - Oslo Stock Exchange |
Vedlegg
- Attachment 251124.pdf (application/pdf, originaldokument)
Meldingstekst
Oslo, Norway, November 24, 2025 - Primary insider Michael Engsig, Chief Executive Officer of Nykode Therapeutics ASA, has today acquired 46,356 shares in Nykode Therapeutics ASA at a price of NOK 2.16 per share. Following the transaction, Michael Engsig holds 118,150 shares in Nykode Therapeutics ASA.
Please see further details in the attached document.